--- title: "Innospec Inc. (NASDAQ:IOSP) Shares Sold by Dimensional Fund Advisors LP" description: "Dimensional Fund Advisors LP reduced its stake in Innospec Inc. (NASDAQ:IOSP) by 0.9% in Q2, owning 1,188,025 shares after selling 10,939 shares. Other institutional investors also adjusted their posi" type: "news" locale: "en" url: "https://longbridge.com/en/news/214870289.md" published_at: "2024-09-22T07:47:53.000Z" --- # Innospec Inc. (NASDAQ:IOSP) Shares Sold by Dimensional Fund Advisors LP > Dimensional Fund Advisors LP reduced its stake in Innospec Inc. (NASDAQ:IOSP) by 0.9% in Q2, owning 1,188,025 shares after selling 10,939 shares. Other institutional investors also adjusted their positions, with Inspire Advisors LLC increasing its stake by 1.6% and Oppenheimer Asset Management Inc. by 31.4%. Innospec's stock opened at $70.94, with a market cap of $1.79 billion and a PE ratio of 19.01. The company reported EPS of $0.39, exceeding estimates, but revenue fell 9.5% year-over-year. StockNews.com downgraded Innospec from "strong-buy" to "buy." Dimensional Fund Advisors LP reduced its stake in shares of Innospec Inc. (NASDAQ:IOSP - Free Report) by 0.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,188,025 shares of the specialty chemicals company's stock after selling 10,939 shares during the quarter. Dimensional Fund Advisors LP owned about 4.76% of Innospec worth $146,828,000 at the end of the most recent quarter. Other institutional investors and hedge funds have also recently bought and sold shares of the company. Inspire Advisors LLC increased its position in shares of Innospec by 1.6% during the second quarter. Inspire Advisors LLC now owns 6,819 shares of the specialty chemicals company's stock worth $843,000 after purchasing an additional 110 shares in the last quarter. Oppenheimer Asset Management Inc. increased its position in Innospec by 31.4% during the second quarter. Oppenheimer Asset Management Inc. now owns 20,136 shares of the specialty chemicals company's stock worth $2,489,000 after buying an additional 4,812 shares during the period. BOKF NA purchased a new stake in Innospec in the second quarter valued at approximately $329,000. Bahl & Gaynor Inc. boosted its holdings in shares of Innospec by 4.0% in the second quarter. Bahl & Gaynor Inc. now owns 37,618 shares of the specialty chemicals company's stock valued at $4,649,000 after acquiring an additional 1,457 shares during the period. Finally, Texas Permanent School Fund Corp grew its position in shares of Innospec by 0.6% during the second quarter. Texas Permanent School Fund Corp now owns 21,891 shares of the specialty chemicals company's stock worth $2,706,000 after acquiring an additional 129 shares during the last quarter. 96.64% of the stock is owned by hedge funds and other institutional investors. ## Insiders Place Their Bets In other Innospec news, CFO Ian Cleminson sold 3,398 shares of the business's stock in a transaction on Monday, August 26th. The shares were sold at an average price of $114.74, for a total transaction of $389,886.52. Following the sale, the chief financial officer now directly owns 12,996 shares in the company, valued at approximately $1,491,161.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.52% of the stock is currently owned by company insiders. ## Innospec Price Performance Shares of NASDAQ IOSP opened at $111.94 on Friday. The company has a market cap of $2.79 billion, a PE ratio of 19.01 and a beta of 1.08. The stock has a fifty day moving average price of $115.79 and a 200 day moving average price of $121.78. Innospec Inc. has a 1-year low of $95.69 and a 1-year high of $133.71. Innospec (NASDAQ:IOSP - Get Free Report) last released its earnings results on Tuesday, August 6th. The specialty chemicals company reported $1.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.02. The company had revenue of $435.00 million for the quarter, compared to analysts' expectations of $468.73 million. Innospec had a return on equity of 14.15% and a net margin of 7.90%. The firm's quarterly revenue was down 9.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.28 EPS. Analysts anticipate that Innospec Inc. will post 5.95 earnings per share for the current fiscal year. ## Analyst Upgrades and Downgrades Separately, StockNews.com cut shares of Innospec from a "strong-buy" rating to a "buy" rating in a research note on Thursday, August 8th. **View Our Latest Stock Analysis on IOSP** ## Innospec Profile (Free Report) Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels. ## Read More - Five stocks we like better than Innospec - Airline Stocks - Top Airline Stocks to Buy Now - Take Advantage of Village Farms Stock as Cannabis Market Evolves - How Technical Indicators Can Help You Find Oversold Stocks - MarketBeat Week in Review – 9/16 - 9/20 - What Investors Need to Know About Upcoming IPOs - Don’t Miss These 3 Retail Stocks for Fall Gains *This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.* → Trump’s weapon lurks in abandoned America (From Porter & Company) (Ad)## Should you invest $1,000 in Innospec right now? Before you consider Innospec, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list. While Innospec currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [IOSP.US - Innospec](https://longbridge.com/en/quote/IOSP.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | 英诺斯派材料｜10-K：2025 财年营收 17.78 亿美元不及预期 | | [Link](https://longbridge.com/en/news/276255259.md) | | 英诺斯派材料｜8-K：2025 财年 Q4 营收 4.56 亿美元不及预期 | | [Link](https://longbridge.com/en/news/276219728.md) | | 谷歌突然发布 Gemini 3.1 Pro：核心推理性能直接翻倍 | 谷歌发布了最新的大模型 Gemini 3.1 Pro，其推理性能较去年发布的 Gemini 3 Pro 翻倍。在 ARC-AGI-2 评测中，Gemini 3.1 Pro 得分 77.1%，显示出强大的推理能力。新模型支持多源数据综合和复杂 | [Link](https://longbridge.com/en/news/276396515.md) | | Copilot+Azure 巩固领先优势 花旗重申微软 “买入” 评级 | 花旗重申对微软的 “买入” 评级，认为其 Copilot 业务动能增强和 Azure 云业务稳健，巩固了在企业级 AI 软件领域的领先地位。分析师 Radke 指出，管理层对投资者关心的竞争格局和资源分配等问题进行了积极回应，缓解了市场担忧 | [Link](https://longbridge.com/en/news/276455595.md) | | 特斯拉在美国推出更便宜的 Cybertruck 车型，售价 59990 美元 | 特斯拉在美国推出了售价为 59990 美元的更便宜的 Cybertruck 车型，使其成为最实惠的版本。同时，特斯拉将最贵的 Cybertruck 车型 Cyberbeast 的价格下调至 99990 美元。此次降价还意味着特斯拉将停止豪华 | [Link](https://longbridge.com/en/news/276410759.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.